AstraZeneca
Stock Forecast, Prediction & Price Target
AstraZeneca Financial Estimates
AstraZeneca Revenue Estimates
AstraZeneca EBITDA Estimates
AstraZeneca Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| £37.41B N/A | £44.35B 18.53% | £45.81B 3.29% | Avg: £55.40B Low: £51.98B High: £59.51B avg. 20.94% | Avg: £58.57B Low: £54.70B High: £62.24B avg. 5.72% | Avg: £62.66B Low: £58.52B High: £66.59B avg. 6.98% | Avg: £65.29B Low: £60.97B High: £69.38B avg. 4.18% |
Net Income
% change YoY
| £112M N/A | £3.28B 2835.71% | £5.95B 81.11% | Avg: £10.48B Low: £12.06B High: £14.86B avg. 76.13% | Avg: £11.74B Low: £13.88B High: £16.15B avg. 12.00% | Avg: £17.76B Low: £16.23B High: £19.21B avg. 51.24% | Avg: £19.19B Low: £17.54B High: £20.75B avg. 8.02% |
EBITDA
% change YoY
| £7.56B N/A | £9.32B 23.29% | £13.42B 43.90% | Avg: £14.60B Low: £13.70B High: £15.69B avg. 8.84% | Avg: £15.44B Low: £14.42B High: £16.41B avg. 5.72% | Avg: £16.52B Low: £15.43B High: £17.55B avg. 6.98% | Avg: £17.21B Low: £16.07B High: £18.29B avg. 4.18% |
EPS
% change YoY
| $0.08 N/A | $2.12 2550% | $3.81 79.71% | Avg: $8.51 Low: $7.72 High: $9.52 avg. 123.49% | Avg: $9.6 Low: $8.89 High: $10.34 avg. 12.78% | Avg: $11.37 Low: $10.4 High: $12.3 avg. 18.44% | Avg: $12.29 Low: $11.23 High: $13.29 avg. 8.02% |
Operating Expenses
% change YoY
| £23.92B N/A | £28.20B 17.88% | £29.57B 4.87% | Avg: £24.04B Low: £22.55B High: £25.82B avg. -18.72% | Avg: £25.41B Low: £23.73B High: £27.00B avg. 5.72% | Avg: £27.19B Low: £25.39B High: £28.89B avg. 6.98% | Avg: £28.32B Low: £26.45B High: £30.10B avg. 4.18% |
FAQ
What is AstraZeneca stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 36.85% in 2025-2028.
We have gathered data from 18 analysts. Their low estimate is 12.06B, average is 10.48B and high is 14.86B.
What is AstraZeneca stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9.46% in 2025-2028.
We have gathered data from 27 analysts. Their low revenue estimate is £51.98B, average is £55.40B and high is £59.51B.
What is AstraZeneca stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 40.68% in 2025-2028.
We have gathered data from 18 analysts. Their low earnings per share estimate is $7.72, average is $8.51 and high is £9.51.